Last Published 07.01.2026 Effective Date: 07.01.2026 This policy addresses certain elective procedures that are typically performed in an office setting but may be performed in an ambulatory surgical center in certain circumstances
When a drug is in shortage, compounders may be able to prepare a compounded version of that drug if they meet certain requirements of the Federal Food, Drug, and Cosmetic (FD&C) Act, the FDA says, but the agency does not review these compounded versions for safety, effectiveness or quality
"Incretin mimetics as a novel therapeutic option for hepatic steatosis"
03 Get your personalized plan If approved, your provider determines the most appropriate treatment for your goals and health profile
Conversely, poor medication adherencemissing doses or inconsistent injection timingdisrupts steady-state pharmacokinetics and delays therapeutic benefits